Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;3(4):947-53.
doi: 10.1002/cam4.255. Epub 2014 May 3.

Steroid treatment increases the recurrence of radiation-induced organizing pneumonia after breast-conserving therapy

Keisuke Otani  1 , Kinji Nishiyama, Yuri Ito, Yoshifumi Kawaguchi, Hideo Inaji
Affiliations

Steroid treatment increases the recurrence of radiation-induced organizing pneumonia after breast-conserving therapy

Keisuke Otani et al. Cancer Med. 2014 Aug.

Abstract

Radiation-induced organizing pneumonia (RIOP) is an important complication of postoperative radiotherapy for breast cancer. Unfortunately, conventional corticosteroid therapy is frequently associated with relapses. The aim of this retrospective study was to evaluate the outcomes of steroid treatment in patients with RIOP. In total, 26 patients diagnosed with RIOP from among 2404 women who received radiotherapy after breast-conserving surgery for breast cancer were included and classified into steroid (n = 7) and nonsteroid (n = 19) groups. Serum, sputum, and bronchoalveolar lavage composition; subjective symptoms (cough, fever, and dyspnea); migratory progression; and RIOP relapse were compared between the groups. Treatment type did not affect the duration of the subjective symptoms, which was 1.6 and 1.7 months for the steroid and nonsteroid groups, respectively. In contrast, RIOP relapse and new pulmonary lesions developed in five patients in the steroid group and only three patients in the nonsteroid group (P = 0.014). By assessing RIOP duration as the time to resolution of symptoms and discontinuation of therapy, the median duration of RIOP was significantly longer in the steroid (17.1 months) than that in the nonsteroid group (2.3 months, P = 0.005), primarily because of frequent relapses. After remission, persistent pulmonary dysfunction did not occur in the nonsteroid group. This single-center retrospective study demonstrates that steroid therapy results in frequent relapses and significantly prolongs RIOP duration. Corticosteroid treatment is considered a critical factor in RIOP recurrence.

Keywords: Breast cancer; breast-conserving therapy; organizing pneumonia; radiation-induced lung injury; steroid therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Respiratory function during and after RIOP. (a–e) nonsteroid group; (f) patient in nonsteroid group who began steroid therapy after relapse (case 26); (g–i): steroid group.
See this image and copyright information in PMC

References

    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 2002;347:1233–1241. - PubMed
    1. Crestani B, Kambouchner M, Soler P, Crequit J, Brauner M, Battesti J-P, et al. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. Eur. Respir. J. 1995;8:318–321. - PubMed
    1. Bayle JY, Nesme P, Bejui-Thivolet F, Loire R, Guerin JC. Cordier JF. Migratory organizing pneumonitis “primed” by radiation therapy. Eur. Respir. J. 1995;8:322–326. - PubMed
    1. Crestani B, Valeyre D, Roden S, Wallaert B, Dalphin JC. Cordier JF. Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The groupe d'etudes et de recherche sur les maladies orphelines pulmonaires (germ”o”p) Am. J. Respir. Crit. Care Med. 1998;158:1929–1935. - PubMed
    1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002;2002:277–304. - PubMed

Substances